229 related articles for article (PubMed ID: 26016809)
21. Transcriptomic profiling in human mesangial cells using patient-derived lupus autoantibodies identified miR-10a as a potential regulator of IL8.
Tangtanatakul P; Thammasate B; Jacquet A; Reantragoon R; Pisitkun T; Avihingsanon Y; Leelahavanichkul A; Hirankarn N
Sci Rep; 2017 Nov; 7(1):14517. PubMed ID: 29109423
[TBL] [Abstract][Full Text] [Related]
22. Identification of plasma miR-106a-5p and miR-30a-5p as potential biomarkers for mesangial proliferative glomerulonephritis.
Wang L; Lin J; Yu T; Zuo Q; Shen B; Zhang H; Liu B; Cai D; Mao H; Zhao H; Zou Q; Xiao B
Clin Biochem; 2020 Oct; 84():79-86. PubMed ID: 32673627
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-155 Suppresses Mesangial Cell Proliferation and TGF-β1 Production via Inhibiting CXCR5-ERK Signaling Pathway in Lupus Nephritis.
Kong J; Li L; Lu Z; Song J; Yan J; Yang J; Gu Z; Da Z
Inflammation; 2019 Feb; 42(1):255-263. PubMed ID: 30209639
[TBL] [Abstract][Full Text] [Related]
24. Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.
Ngamjanyaporn P; Worawichawong S; Pisitkun P; Khiewngam K; Kantachuvesiri S; Nongnuch A; Assanatham M; Sathirapongsasuti N; Kitiyakara C
PLoS One; 2022; 17(3):e0263778. PubMed ID: 35271583
[TBL] [Abstract][Full Text] [Related]
25. Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis.
Singh S; Wu T; Xie C; Vanarsa K; Han J; Mahajan T; Oei HB; Ahn C; Zhou XJ; Putterman C; Saxena R; Mohan C
Arthritis Res Ther; 2012 Jul; 14(4):R164. PubMed ID: 22788914
[TBL] [Abstract][Full Text] [Related]
26. MiR-145 participates in the development of lupus nephritis by targeting CSF1 to regulate the JAK/STAT signaling pathway.
Liao W; He XJ; Zhang W; Chen YL; Yang J; Xiang W; Ding Y
Cytokine; 2022 Jun; 154():155877. PubMed ID: 35468468
[TBL] [Abstract][Full Text] [Related]
27. miR-1968-5p is involved in the pathogenesis of lupus nephritis of NZBWF1 mice by targeting csf1.
Li S; Wang X; Zhu X; Xue Y; Zhang J; Tan X; Deng J; Li C; Kuang W; Li C
Clin Exp Nephrol; 2021 Nov; 25(11):1173-1181. PubMed ID: 34231109
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of Serum MiR-130b-3p Level is Associated with Renal Damage in Early Lupus Nephritis.
Wang W; Mou S; Wang L; Zhang M; Shao X; Fang W; Lu R; Qi C; Fan Z; Cao Q; Wang Q; Fang Y; Ni Z
Sci Rep; 2015 Aug; 5():12644. PubMed ID: 26316103
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of renal gene expression of protein kinase C (PKC) isoforms in diabetic and nondiabetic proliferative glomerular diseases.
Ibrahim S; Rashed L; Fadda S
ScientificWorldJournal; 2008 Aug; 8():835-44. PubMed ID: 18758661
[TBL] [Abstract][Full Text] [Related]
30. Urinary sediment ICAM-1 level in lupus nephritis.
Guan J; Wang G; Tam LS; Kwan BC; Li EK; Chow KM; Li PK; Szeto CC
Lupus; 2012 Oct; 21(11):1190-5. PubMed ID: 22685016
[TBL] [Abstract][Full Text] [Related]
31. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
32. Effect of mycophenolate and rapamycin on renal fibrosis in lupus nephritis.
Zhang C; Chan CCY; Cheung KF; Chau MKM; Yap DYH; Ma MKM; Chan KW; Yung S; Chan TM
Clin Sci (Lond); 2019 Aug; 133(15):1721-1744. PubMed ID: 31358596
[TBL] [Abstract][Full Text] [Related]
33. Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis.
Navarro-Quiroz E; Pacheco-Lugo L; Navarro-Quiroz R; Lorenzi H; España-Puccini P; Díaz-Olmos Y; Almendrales L; Olave V; Gonzalez-Torres H; Diaz-Perez A; Dominguez A; Iglesias A; García R; Aroca-Martinez G
PLoS One; 2017; 12(11):e0187973. PubMed ID: 29136041
[TBL] [Abstract][Full Text] [Related]
34. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis.
Wu T; Xie C; Wang HW; Zhou XJ; Schwartz N; Calixto S; Mackay M; Aranow C; Putterman C; Mohan C
J Immunol; 2007 Nov; 179(10):7166-75. PubMed ID: 17982109
[TBL] [Abstract][Full Text] [Related]
35. Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis.
Zykova SN; Tveita AA; Rekvig OP
PLoS One; 2010 Aug; 5(8):. PubMed ID: 20856893
[TBL] [Abstract][Full Text] [Related]
36. Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis.
Tucci M; Barnes EV; Sobel ES; Croker BP; Segal MS; Reeves WH; Richards HB
Arthritis Rheum; 2004 Jun; 50(6):1842-9. PubMed ID: 15188361
[TBL] [Abstract][Full Text] [Related]
37. Association of miRNA-145 expression in vascular smooth muscle cells with vascular damages in patients with lupus nephritis.
Ding Y; Liao W; Yi Z; Xiang W; He X
Int J Clin Exp Pathol; 2015; 8(10):12646-56. PubMed ID: 26722454
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients.
Dai Y; Sui W; Lan H; Yan Q; Huang H; Huang Y
Rheumatol Int; 2009 May; 29(7):749-54. PubMed ID: 18998140
[TBL] [Abstract][Full Text] [Related]
39. An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus Nephritis.
Solé C; Moliné T; Vidal M; Ordi-Ros J; Cortés-Hernández J
Cells; 2019 Jul; 8(8):. PubMed ID: 31349698
[TBL] [Abstract][Full Text] [Related]
40. Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.
Devarapu SK; Kumar Vr S; Rupanagudi KV; Kulkarni OP; Eulberg D; Klussmann S; Anders HJ
Clin Immunol; 2016 Aug; 169():139-147. PubMed ID: 27392463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
